News
What Johnson & Johnson and Eli Lilly are saying about Trump’s pharmaceutical tariffs, and Dexcom scores FDA approval for its ...
The Diabetes Link organization organized a diabetes tech seminar that brought together individuals with Type 1 diabetes, ...
The following is a summary of “Evidence for improved glucose metrics and perinatal outcomes with continuous glucose ...
The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with diabetes.
Glucotrack (Nasdaq:GCTK) announced today that it intends to participate in a bionic pancreas initiative in Europe.
Self-monitoring blood sugar levels has become trendy for people who don't have diabetes. In most cases, however, there is no need to micromanage your blood sugar spikes and dips.
Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results